期刊文献+

多发性肌炎、皮肌炎合并肺间质性肺炎的诊治 被引量:2

Diagnosis and Treatment of Polymyositis and Dermatomyositis with Pulmonary Interstitial Pneumonia
下载PDF
导出
摘要 多发性肌炎(PM)、皮肌炎(DM)的死亡原因多种多样,合并肺间质性肺炎是其最主要的死亡原因。在合并间质性肺炎的皮肌炎及多发性肌炎患者中,中性粒细胞与淋巴细胞比值、血浆白蛋白与C反应蛋白比值、铁蛋白、IL-6、IL-8、IL-10明显升高,PM/DM患者的肺功能检查常显示弥散功能较差。HRCT是检测肺部间质性疾病的主要手段,不同类型的间质性肺炎影像学表现不同。目前,关于PM/DM合并间质性肺炎患者的治疗尚未明确规定,本文现就多发性肌炎、皮肌炎合并肺间质性肺炎的血清学检查、肺功能检查、影像学表现以及治疗作一综述。 The causes of death in polymyositis(PM)and dermatomyositis(DM)are various.Complicated pulmonary interstitial pneumonia is the main cause of death.In patients with dermatomyositis and polymyositis with interstitial pneumonia,neutrophil to lymphocyte ratio,plasma albumin to C-reactive protein ratio,ferritin,IL-6,IL-8,IL-10 significantly increased,pulmonary function tests in patients with PM/DM often show poor diffuse function.HRCT is the main method to detect pulmonary interstitial disease,and different types of interstitial pneumonia have different imaging manifestations.At present,the treatment of PM/DM patients with interstitial pneumonia has not been clearly defined,this article is a review of polymyositis,dermatomyositis combined with pulmonary interstitial pneumonia serological examination,lung function examination,imaging manifestations and treatment.
作者 熊倩 江涛 XIONG Qian;JIANG Tao(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400000,China)
出处 《医学信息》 2020年第6期43-46,共4页 Journal of Medical Information
关键词 多发性肌炎 皮肌炎 肺间质性疾病 Polymyositis Dermatomyositis Interstitial lung disease
  • 相关文献

参考文献4

二级参考文献38

  • 1周亚欧,左晓霞,游运辉,罗卉.皮肌炎/多发性肌炎肺间质病变的临床及相关因素分析[J].中华风湿病学杂志,2005,9(5):318-319. 被引量:25
  • 2崔平,田素伟,韩铭钧.系统性红斑狼疮肺部病变的HRCT检查[J].放射学实践,2005,20(10):890-892. 被引量:6
  • 3高恺言,邹耀红,俞可佳.无肌炎的皮肌炎9例临床分析[J].南京医科大学学报(自然科学版),2006,26(5):381-382. 被引量:4
  • 4王亚丽,郑国,赵伟,刘荣欣,张雪.多发性肌炎/皮肌炎与系统性硬皮病的肺部病变及差异性比较(附92例HRCT报告)[J].中国医学影像技术,2006,22(8):1191-1193. 被引量:3
  • 5Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interstitial lung disease associated with clinically amyo- pathic dermatomyositis and classic dermatomyositis. Chest, 2009, 136: 1341-1347.
  • 6Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140- kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum, 2005, 52: 1571- 1576.
  • 7Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine' myositis) as a distinctive subset within the idiopathic inflammatory dermatomy- opathies spectrum of clinical illness. J Am Acad Dermatol, 2002, 46: 626-636.
  • 8American Thoracic Society. Idiopathic pulmonary fibrosis:diagno- sis and treatment. International consensus statemento American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med, 2000, 161: 646-664.
  • 9Sato S, Hoshino K, Satoh T, et al. MDA5 (melanoma a-different iation associated gene as an autoantigen recognised by anti- CADM-140 antibody in patients with clinically amyopathic der- matomyositis (abstract). Arthritis Rheum, 2008, 58 : S923.
  • 10Takeuchi O, Akira S. MDAS/RIG- I and virus recognition. Curr Opin Immunol, 2008, 20: 17-22.

共引文献39

同被引文献27

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部